Maravai Lifesciences Holdings, Inc. (MRVI)
2.86
-0.23
(-7.44%)
USD |
NASDAQ |
Mar 27, 16:00
2.855
0.00 (0.00%)
After-Hours: 20:00
Maravai Lifesciences Holdings Debt to Equity Ratio : 1.717 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arcutis Biotherapeutics, Inc. | 0.6028 |
| ACADIA Pharmaceuticals, Inc. | 0.0425 |
| MiMedx Group, Inc. | 0.0878 |
| ADMA Biologics, Inc. | 0.1674 |
| Arcus Biosciences, Inc. | 0.3138 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 770.58M |
| Total Liabilities (Quarterly) | 397.87M |
| Shareholders Equity (Quarterly) | 212.38M |
| Current Ratio | 6.596 |
| Net Debt Paydown Yield | 8.32% |